Pattern of adverse events induced by aflibercept and ranibizumab: A nationwide spontaneous adverse event reporting database, 2007–2016

Data regarding the safety of anti-vascular endothelial growth factor (anti-VEGF) treatment is limited. To compare the adverse events (AEs) induced by aflibercept and ranibizumab using a spontaneous reporting system and determine the signals. We used data from the Korea Institute of Drug Safety &...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Dongmun, Choi, So-Ra, Kwon, Yongmin, Park, Han-Heui, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831246/
https://www.ncbi.nlm.nih.gov/pubmed/31415382
http://dx.doi.org/10.1097/MD.0000000000016785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831246/
https://www.ncbi.nlm.nih.gov/pubmed/31415382
http://dx.doi.org/10.1097/MD.0000000000016785

Ejemplares similares